Search results
Ozempic® (semaglutide) injection 1 mg demonstrated reduction in risk of kidney disease-related...
Benzinga· 16 hours agoSemaglutide 1 mg demonstrated a statistically significant and superior reduction of 24% in the risk of kidney disease-related events vs. placebo in adults with type ...
Intermittent fasting may help type 2 diabetics control blood sugar - study
Euronews via Yahoo News· 22 hours agoShe reviewed the findings but was not involved with the study. Across the globe, about 1 in 10...
Can Metformin Cause Hair Loss?
MediaFeed via AOL· 22 hours agoMetformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this medication, the connection might...
Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial
Clinical Trials Arena via Yahoo Finance· 23 hours ago"Vertex’s VX-880 shows promise in Phase I/II type 1 diabetes trial" was originally created and...
... Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American ...
Morningstar· 3 days agoThe survey found that 86 percent of... Mobi regardless of prior therapy and agreed that Tandem Mobi helps improve their quality of life.1 Tandem Mobi, the world’s smallest ...
Postdoctoral position for EU project ARTiDe: A novel regulatory T celltherapy for type 1 diabetes -...
Nature· 5 days agoType 1 diabetes (T1D) is an incurable disease, often starting in childhood, caused by the autoimmune destruction of insulin-producing ...
Medtronic’s study shows reduced diabetes burden with MiniMed 780G system
Medical Device Network via Yahoo Finance· 24 hours agoMedtronic has reported positive results from a study of its MiniMed 780G automated insulin delivery...
ADA Scientific Sessions 2024 Go Beyond Glucose and Obesity
Medscape· 6 days agoScientific Sessions committee chair Alice Cheng, MD, told Medscape Medical News, "What we're going...
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes...
Benzinga· 16 hours agoToday, findings from the landmark FLOW trial, the first dedicated kidney outcomes trial with a GLP-1 (glucagon-like peptide-1) receptor agonist were reported ...
Intermittent fasting over two days can help people with Type 2 diabetes
Anchorage Daily News· 1 day agoIntermittent fasting can help people with Type 2 diabetes lose weight, lower blood pressure and...